Japan signs deal to secure 120 million doses of potential Covid-19 vaccine
Financial details of the deal to secure 120 million doses of a potential coronavirus vaccine were not disclosed, with German pharmaceutical group BioNTech saying the terms were based on the timing of the delivery and volume of doses. First deliveries to Japan are planned for the first half of 2021. BioNTech is developing a potential vaccine with US pharma giant Pfizer.